GlaxoSmithKline has announced plans to collaborate ... based vaccine being developed in China by CanSino Biologics and the Beijing Institute of Biotechnology, and Moderna’s mRNA vaccine that ...

Beijing biotech Sironax has closed a whopping $200 million second-round financing that shows investors still have a desire to back companies working on RIPK1 inhibitors despite setbacks for GSK in ...

The journey of AstraZeneca from struggling pharma lightweight under siege from Pfizer to Britain's most valuable company is ...

and other Taiwanese electronics manufacturers continue to diversify their businesses outside of China as tensions rise between Washington and Beijing. — BLOOMBERG NEWS GSK says antibody drug ...

Before joining the foundation in 2007, Ken spent 16 years in the pharmaceutical industry, most recently as director of diseases of the developing world at GlaxoSmithKline ... Health Drug Discovery ...

Beijing-Tianjin-Tanggu expressway runs through ... and the bio-pharmaceutical sector led by GlaxoSmithKline and Novo Nordisk.

DelveInsight’s, “Head and Neck Cancer Pipeline Insight 2024” report provides comprehensive insights about 80+ companies and ...

How is GSK engaging with Chinese academics and other ... seven — agreements with Chinese academic institutions, some in Beijing, Shanghai and Hong Kong. With some groups, we are working very ...

The World Health Organization said on Friday it had cleared Bavarian Nordic's mpox vaccine, the first such shot to be ...

Soriot, who weathered storms in Europe over Covid-19 contracts, faces a very different and more mercurial government in Beijing. GSK, and countless people hanging on to to democracy and free ...